Predicting cardiovascular events in hemodialysis patients based on the fusion of physicochemical indicators and tongue images: a prospective and multicenter study

基于理化指标与舌象融合预测血液透析患者心血管事件:一项前瞻性多中心研究

阅读:3

Abstract

BACKGROUND: Cardiovascular events (CVEs) are the leading cause of mortality in hemodialysis patients. Current prediction models rely on clinical and biochemical data, but non-invasive alternatives are needed. Inspired by the Traditional Chinese Medicine (TCM) principle that "the heart opens into the tongue," this study investigated whether quantitative features from tongue images could enhance CVE prediction. OBJECTIVE: To develop and validate a machine learning framework that integrates tongue image features with conventional clinical variables to predict CVEs in hemodialysis patients. METHODS: In this prospective, multicenter study, 506 maintenance hemodialysis patients were recruited. We extracted 1,354 hand-crafted radiomic features and 8 deep-learning features from standardized tongue images. These were combined with 90 clinical variables. Using a dataset split into training (n=243), validation (n=105), and an independent external test set (n=158), we developed and compared four models (LR, LightGBM, AdaBoost, MLP) under three feature configurations: clinical-only, tongue-only, and a fused model. RESULTS: The model using only tongue image features (AdaBoost) significantly outperformed the clinical-only model, achieving an AUC of 0.786 vs. 0.682 on the external test set. The fused model provided a marginal improvement (AUC=0.787). SHAP analysis indicated that both tongue texture features and clinical biomarkers like PT% were key predictors. Decision curve analysis confirmed the clinical utility of the tongue-based and fused models across a range of risk thresholds. CONCLUSION: Tongue image features are potent, non-invasive predictors of CVEs in hemodialysis patients, offering performance superior to conventional clinical variables. This AI-driven approach validates the TCM theory and presents a promising supplementary tool for enhancing risk stratification in nephrology care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。